- Home
- BCAB vs SSEA Comparison
BCAB vs SSEA Comparison
Compare BCAB & SSEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$0.66
Company Overview
Basic Information| Metric | BCAB | SSEA |
|---|---|---|
| Founded | 2007 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.6M | 76.3M |
| IPO Year | 2020 | 2025 |
Fundamental Metrics
Financial Performance| Metric | BCAB | SSEA |
|---|---|---|
| Price | $0.66 | $10.01 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $1.00 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 53.8K |
| Earning Date | 11-13-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.24 | $9.93 |
| 52 Week High | $1.43 | $10.03 |
Technical Indicators
Market Signals| Indicator | BCAB | SSEA |
|---|---|---|
| Relative Strength Index (RSI) | 40.18 | N/A |
| Support Level | $0.74 | N/A |
| Resistance Level | $0.83 | N/A |
| Average True Range (ATR) | 0.08 | 0.00 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 14.83 | 0.00 |
Price Performance
Historical Comparison BCAB
SSEA
About BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.
About SSEA Starry Sea Acquisition Corp Ordinary Shares
Starry Sea Acquisition Corp is a newly organized blank check company.